High
Resolution Ultrasound
Facilities
and Equipment
A
Siemens Sonoline Elegra,
running the 5.1 software, is
available. The scanner has the full array of transducers
including the 13MHz
1.5D array. This transducer has a focused beam that produces a 1 mm
slice
thickness at the focal zone that can be moved from the near to the far
field
with an imaging window as small as 2 cm wide by 1.5 cm deep and a 150
micron
axial resolution at the focal zone producing exquisite detail (Figures
7-9 below).
The 2D frame-rate is sufficiently high to freeze respiratory and
cardiac
motion. Duplex and color Doppler as well as M-mode and 3D are all
available on
the 13MHz transducer. The detail and information content of images
indicate
that 13MHz imaging of mice can detect tumors in the liver or deep
tissues.
Service
Non-destructive, rapid,
high spatial and contrast
resolution imaging of live mice that could potentially be done in a
sterile
environment and without anesthesia, provides a powerful tool to monitor
superficial and deep tumors. It is well known that subcutaneous tumors
exhibit
different vascular morphology without the influence of their native
host tissue
[1].
Ultrasound provides the ability to detect and monitor deep tumors
analogous to
physical examination of superficial tumors with minimal risk to the
animal.
Specific services include:
- Monitoring
of in situ tumor growth
- Left
ventricular volume measurement
- Imaging
in a sterile environment
- Tumor
viability and quantification of
relative blood flow and
blood volume with contrast media.
Structural
In-Vivo Imaging of
Live Mice
Ultrasound
is a
practical imaging tool that can image mice in real-time at high frame
rates. It
is ideally suited at imaging naturally occurring tumors and monitoring
their
growth (Figure 7) and because of the small size of mice can easily
distinguish
small intraperitoneal tumors from bowel (Figure 8). Because of the high
resolution available at high frequency, it can image the liver of a
mouse to
detect metastases (Figure 9). Further, the availability of ultrasound
contrast
media allows the visualization of tumor vessels (Figure 8 & 9).
While it is
difficult to perform CT and MRI in a sterile environment, ultrasound
imaging can
be performed in a sterile fashion as is currently done with
intra-operative
ultrasound. The unit is draped with a sterile, transparent cover
allowing
access to the unit’s controls and the transducer is placed in
a sterile sleeve
preventing contamination of the scanning field.
The ultrasound images shown
in Figures 7-9 were acquired
while the animals were anesthetized. To minimize animal loss due to
anesthesia,
we will image mice in a sterile fashion but without anesthesia, when no
intravenous administration is required. Since nude mice do not require
shaving
and since ultrasound acquires images in real-time, contact with skin
and motion
will not hinder the ability to survey the animal’s abdomen.
This can be
accomplished by having an assistant immobilize the animal by holding it
with
the dorsal skin, as is done during intraperitoneal injections, by one
hand and
holding the hind legs to slightly stretch the abdomen by the other. The
sonographer can then quickly scan the abdomen to survey for the
presence and
size of tumors. A non-nude mouse can be anesthetized with Isofluorane,
a quick
acting anesthetic, to allow for shaving, and then it can be imaged
while
non-anesthetized. While it can be argued that stress could affect the
animals’
physiology, anesthesia has more depressing effects on mice.
Nonetheless,
imaging without anesthesia is not intended to image physiology that
requires
contrast administration, rather, it is intended to detect and monitor
the
anatomy of tumors analogous to a physical exam.


Images
acquired using the Matrigel angiogenesis model described were exquisite
(Figure
10). They allowed the visualization of the angiogenic vascular plug
before
ultrasound contrast was administered because of the heterogeneous
architecture
where vessels developed in the bFGF-impregnated homogeneous Matrigel.
When
contrast was administered, dramatic enhancement of the perfused vessels
occurred (arrows in Figure 10).
Sterile
Imaging will be
performed by first wiping down
the unit with disinfecting solution and wheeling it into the treatment
room.
Sterile Gel will be placed between the transducer surface and the
sterile
sleeve covering it and its cable. The unit will be covered with a
sterile
plastic transparent drape to allow access to its controls. The
sonographer will
gown and glove according to protocol. For standard monitoring of tumor
size,
nude mice will be scanned without anesthesia as described above using a
small
amount of sterile warm gel for contact. When a tumor is detected,
images will be
acquired with internal landmarks to allow session to session or post
mortem
confirmation, and tumor dimensions will be measured and images stored
digitally.
Functional
In-Vivo Imaging
of Live Nude Mice
Relative
blood flow and
fractional blood volume indices
can be assessed with ultrasound contrast intermittent imaging [2
- [iii][iv]5].
Further, we also showed that fractional blood volume, determined by
intermittent imaging following long interscan delay using a Vx2 tumor
model,
correlates with microvascular density, an index of angiogenesis.
Therefore, it
is possible to determine tumor vascularity and angiogenesis and
possibly the
effect of anti-angiogenic therapy. Since imaging sessions can be
performed
repeatedly, particularly if done with quick anesthesia to place an IV
line,
tumor response to interventions such as an anti-angiogenesis therapy
can be
monitored as frequently and for as long as desired for longitudinal
experiments. Assessing relative blood flow using the destruction model [6]
rather than the destruction reperfusion model requires only 2 or 3
seconds
without animal motion as compared to 15 sec.
1.
Roberts
WG (1998), Delaat J, Nagane M, Huang S, Cavenee WK, Palade
GE. Host
microvasculature influence on tumor vascular morphology and endothelial
geen
expression. Amer J Path 153;1239-1248.
2.
Wei
K (1998), Jayaweera AR, Firoozan S, et al. Quantification of myocardial
blood
flow with ultrasound-induced destruction of microbubbles administered
as a constant
venous infusion. Circulation 97:473-83.
3.
Villanueva
FS (2002), Abraham JA, Schreiner GF, et al. Myocardial contrast
echocardiography can be used to assess the microvascular response to
vascular
endothelial growth factor-121. Circulation 105:759-65.
4.
Kono
Y (2000), Mattrey RF,Summers H, Baker K, Steinbach G. Visualization of
Tumor
Vessels with Ultrasound Contrast and the Potential for Quantitative
Analysis of
Relative Tumor Blood Flow and Fractional Blood Volume. AIUM 44th Annual
Convention, San Francisco, J Ultrasound Med 19: S59.
5.
Mattrey
RF (1998), Peterson TM, Baker KG, Dieranieh LH, Lee YZ, Steinbach GC:
The Use
of Ultrasound Contrast to Quantify Kidney Perfusion with B-mode
Imaging. RSNA, Chicago, Radiology 209:461.
6.
Lucidarme
O (2003), Kono Y, Corbeil J, Choi SH, Mattrey RF. Validation of
ultrasound
contrast destruction imaging for flow quantification. Ultrasound
Med Biol
29:1697-704.